Equity Overview
Price & Market Data
Price: $4.36
Daily Change: -$0.13 / 2.98%
Daily Range: $4.35 - $4.51
Market Cap: $548,514,048
Daily Volume: 4,136,447
Performance Metrics
1 Week: -4.16%
1 Month: -5.19%
3 Months: -5.81%
6 Months: 20.66%
1 Year: -33.94%
YTD: 21.33%
Company Details
Employees: 59
Sector: Health technology
Industry: Biotechnology
Country:
Details
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.